The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
Name | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.6% |
Nucor | 2.6% |
JP Morgan | 2.6% |
Hartford Financial | 2.5% |
Morgan Stanley | 2.5% |
Wells Fargo | 2.5% |
Pfizer | 2.5% |
Apache | 2.5% |
Cigna | 2.5% |
Key | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.6% |
Nucor | 2.6% |
JP Morgan | 2.6% |
Other | 89.5% |
Date | 23-Jun-2022 |
---|---|
NAV | 157.11p |
Currency | GBP |
Change | 1.74p |
% | 1.12% |
YTD change | 157.11p |
YTD % | n/a |
Fund Inception | 01/07/2005 |
---|---|
Fund Manager | Richard Brody |
TER | 1.68 (28-Feb-2014) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | £10 |
Savings | £10 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | 4.50% |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.02 |
You are here: research